Skip to main content

Table 1 Demographic characteristic regarding fibrosis degree (fibrosis versus cirrhosis) in non-diabetic and diabetic group

From: Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes

Variable

Liver fibrosis

Significance

Liver cirrhosis

Significance

GI a no-diabetes

(n = 40)

GII a diabetic

(n = 40)

p value

GI b no-diabetes

(n = 40)

GII b diabetic

(n = 40)

p value

Age (years)

      

Mean ± SD

Range

39.45 ± 9.07

23–58

41.55 ± 7.57

24–57

0.26

(U test)

40.79 ± 11.65

20–64

57.58 ± 4.39

45–70

 < 0.001***

(U test)

BMI:

(Kg/m2)

      

Mean ± SD

Range

25.69 ± 2.42

22–34

27.57 ± 2.74

20–32

0.001***

(U test)

24.98 ± 3

20–31

25 ± 2

22–29

0.97

(U test)

Sex

      

Male n (%)

22 (55%)

28 (70%)

0.58

(χ2 test)

32 (80%)

31 (77.5%)

0.78

(χ2 test)

Female n (%)

18 (45%)

12 (30%)

8 (20%)

9 (22.5%)

  1. ***Highly significant p < 0.001 U: Mann–Whitney test